Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,762.00
(
-1.53%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.20
(
6.51%
)
Bitcoin
71,328.51
(
-3.54%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122794
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biopearl post# 4771

Friday, 08/24/2007 10:53:23 AM

Friday, August 24, 2007 10:53:23 AM

Post# of 19309
>Is the control arm in the phase III ART-123 study heparin or nothing?<

The ART-123 program has not yet reached phase-3; in phase-2b (the trial that was just announced), the control arm is placebo, according to the description at http://www.clinicaltrials.gov/ct/show/NCT00487656 . Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now